AT168063B - Process for the preparation of new asymmetric substitution products of 2,4-diamino-1,3,5-triazine - Google Patents
Process for the preparation of new asymmetric substitution products of 2,4-diamino-1,3,5-triazineInfo
- Publication number
- AT168063B AT168063B AT168063DA AT168063B AT 168063 B AT168063 B AT 168063B AT 168063D A AT168063D A AT 168063DA AT 168063 B AT168063 B AT 168063B
- Authority
- AT
- Austria
- Prior art keywords
- diamino
- triazine
- preparation
- substitution products
- new asymmetric
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU168063X | 1948-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AT168063B true AT168063B (en) | 1951-04-10 |
Family
ID=10977807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT168063D AT168063B (en) | 1948-11-23 | 1949-11-08 | Process for the preparation of new asymmetric substitution products of 2,4-diamino-1,3,5-triazine |
Country Status (1)
Country | Link |
---|---|
AT (1) | AT168063B (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2829143A (en) * | 1957-03-13 | 1958-04-01 | Sterling Drug Inc | 2-(4-sulfamylphenylamino)-4-amino triazine and acid addition salts |
US2928768A (en) * | 1956-09-07 | 1960-03-15 | Us Vitamin Pharm Corp | Use of substituted amino-formoguanamines in diuretic therapy |
US2934535A (en) * | 1960-04-26 | Z-amino-x-trifluoromethylanilino-s | ||
US2937173A (en) * | 1959-05-06 | 1960-05-17 | Us Vitamin Pharm Corp | Indolino and tetrahydroquinolino triazines |
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
-
1949
- 1949-11-08 AT AT168063D patent/AT168063B/en active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2934535A (en) * | 1960-04-26 | Z-amino-x-trifluoromethylanilino-s | ||
US2928768A (en) * | 1956-09-07 | 1960-03-15 | Us Vitamin Pharm Corp | Use of substituted amino-formoguanamines in diuretic therapy |
US2829143A (en) * | 1957-03-13 | 1958-04-01 | Sterling Drug Inc | 2-(4-sulfamylphenylamino)-4-amino triazine and acid addition salts |
US2937173A (en) * | 1959-05-06 | 1960-05-17 | Us Vitamin Pharm Corp | Indolino and tetrahydroquinolino triazines |
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT168063B (en) | Process for the preparation of new asymmetric substitution products of 2,4-diamino-1,3,5-triazine | |
CH286345A (en) | Process for the preparation of 1- (4'-oxy-phenyl) -2-isopropylamino-ethanone. | |
CH258755A (en) | Process for the preparation of 3,4-dichloro-1-tetrachloro-ethylbenzene. | |
CH293015A (en) | Process for the preparation of 1-phenyl-1-pyridyl- (2 ') -3-N-pyrrolidino-propane-p-amino-salicylate. | |
CH280198A (en) | Process for the preparation of copolymers. | |
CH281752A (en) | Process for the preparation of 1,4-diketo-5-methyl-1,4,5,8,9,10-hexahydro-naphthalene. | |
CH266997A (en) | Process for the preparation of 3,4-dimethyl-5-phenyl-2-imino-thiazolidine. | |
AT170029B (en) | Process for the preparation of new 4,7-phenanthrolines | |
AT171155B (en) | Process for the preparation of the new 3,4-dimethyl-5-phenyl-2-imino-thiazolidine | |
CH330306A (en) | Process for the preparation of 1- (3 ', 4'-dioxyphenyl) -1-oxo-2-aralkylamino-ethane | |
CH274521A (en) | Process for the preparation of 2-phenyl-3,4,5,6-tetrahydrobenzoic acid. | |
AT171704B (en) | Process for the preparation of 1-benzyl-1,2,3,4,5,6,7,8-octahydroisoquinoline | |
CH268532A (en) | Process for the preparation of aminotriazine derivatives. | |
AT174903B (en) | Process for the preparation of the new 1,2,3,4-tetrahydrofluorenone | |
CH281278A (en) | Process for the preparation of 1-phenyl-2-aminopropane. | |
AT174057B (en) | Process for the preparation of 3,4-methylenedioxy-1-β-aminopropylbenzene | |
AT174907B (en) | Process for the preparation of new 2,3-dihydropyran-2,4-dione | |
AT170884B (en) | Process for the preparation of new 2,3-dihydropyran-2,4-dione | |
AT177526B (en) | Process for the preparation of 17,20-oxy-ketones of the Pregnan series | |
AT170864B (en) | Process for the preparation of new Methylbenzhydryl-β-morpholinoäthyläthern | |
AT171708B (en) | Process for the preparation of new m-alkoxy-phenyl-isothiocyanates | |
AT172634B (en) | Process for the preparation of new thiocarbhydrazine compounds | |
AT173693B (en) | Process for the preparation of new diphenylyl compounds | |
AT175567B (en) | Process for the preparation of new iminoisoindolenine derivatives | |
CH281125A (en) | Process for the preparation of thiosemicarbazide. |